Skip to main content
. 2020 Oct 20;2020(10):CD004908. doi: 10.1002/14651858.CD004908.pub3

Summary of findings 5. Paracetamol compared to NSAID for relief of pain due to uterine cramping/involution after birth.

Paracetamol compared to NSAID for relief of pain due to uterine cramping/involution after birth
Patient or population: women who have given birth vaginally, requiring analgesia for after‐birth pains.
Setting: hospital obstetric inpatients (Norway, and USA)
Intervention: paracetamol
Comparison: NSAID
Outcomes № of participants
(studies) Certainty of the evidence
(GRADE) Relative effect
(95% CI) Anticipated absolute effects* (95% CI)
Risk with NSAID Risk difference with paracetamol
Adequate pain relief as reported by the woman
(6 hours)
48
(1 RCT) ⊕⊝⊝⊝
VERY LOWa,b RR 0.89
(0.62 to 1.26) Study population
769 per 1000 85 fewer per 1000
(292 fewer to 200 more)
Need for additional pain relief Not reported
Maternal adverse events
(up to 4 hours and at 6 hours)
112
(2 RCTs) ⊕⊝⊝⊝
VERY LOWa,b RR 0.99
(0.52 to 1.86) Study population
241 per 1000 2 fewer per 1000
(116 fewer to 207 more)
Neonatal adverse events Not reported
Duration of hospital stay Not reported
Any breastfeeding at hospital discharge Not reported
Any breastfeeding at 6 weeks postpartum Not reported
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidenceHigh certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

aDowngraded one level due to serious concerns about limitations in study design: risk of bias ‐ unclear risk in most domains.
bDowngraded two levels due to very serious concerns about imprecision: few participants and wide confidence intervals.